Michael Kyriakides

Michael Kyriakides

Investment Partner

Michael Kyriakides is an Investment Partner of Syncona Investment Management Ltd.

He works closely with Syncona portfolio companies Freeline Therapeutics, Purespring Therapeutics and Clade Therapeutics. 

Previously, Michael was a member of the Life Sciences team at L.E.K. Consulting, where he worked in projects for pharmaceutical, biotech and private equity clients. Prior to joining L.E.K. Consulting, he was a clinical project and NMR manager in the Faculty of Medicine at Imperial College London. Michael obtained his doctorate degree in toxicology and metabolic profiling at Imperial College London.

Syncona portfolio companies

  • Freeline Therapeutics
  • Clade Therapeutics (Board observer)
  • Purespring Therapeutics (Board member)
Martin Murphy

Martin Murphy

Chief Executive Officer
Chris Hollowood

Chris Hollowood

Chief Investment Officer
Edward Hodgkin

Edward Hodgkin

Senior Partner
Elisa Petris

Elisa Petris

Lead Partner
Magdalena Jonikas

Magdalena Jonikas

Lead Partner
Alex Hamilton

Alex Hamilton

Investment Partner
Gonzalo Garcia

Gonzalo Garcia

Investment Partner
Alice Renard

Alice Renard

Investment Partner
Raghd Rostom

Raghd Rostom

Associate Partner
Nathaniel Dahan

Nathaniel Dahan

Associate Partner